209 related articles for article (PubMed ID: 26243307)
21. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
22. Comparative hydrolysis of sphingomyelin and 2-N-(hexadecanoyl)-amino-4-nitrophenyl-phosphorylcholine by normal human brain homogenate at acid and neutral pH.
Levade T; Salvayre R; Douste-Blazy L
J Neurochem; 1983 Jun; 40(6):1762-4. PubMed ID: 6304255
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipids in viral infection.
Schneider-Schaulies J; Schneider-Schaulies S
Biol Chem; 2015 Jun; 396(6-7):585-95. PubMed ID: 25525752
[TBL] [Abstract][Full Text] [Related]
24. Ceramide-induced cell death in malignant cells.
Carpinteiro A; Dumitru C; Schenck M; Gulbins E
Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
Claus RA; Dorer MJ; Bunck AC; Deigner HP
Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
[TBL] [Abstract][Full Text] [Related]
27. The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation.
Zeidan YH; Hannun YA
Curr Mol Med; 2010 Jul; 10(5):454-66. PubMed ID: 20540705
[TBL] [Abstract][Full Text] [Related]
28. Neutral sphingomyelinases and nSMase2: bridging the gaps.
Clarke CJ; Hannun YA
Biochim Biophys Acta; 2006 Dec; 1758(12):1893-901. PubMed ID: 16938269
[TBL] [Abstract][Full Text] [Related]
29. Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
Matmati N; Hannun YA
J Lipid Res; 2008 May; 49(5):922-8. PubMed ID: 18305313
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hSMPD2).
Yi J; Qi B; Yin J; Li R; Chen X; Hu J; Li G; Zhang S; Zhang Y; Yang M
Nat Commun; 2023 Nov; 14(1):7755. PubMed ID: 38012235
[TBL] [Abstract][Full Text] [Related]
31. Regulation of sphingomyelinases in cells of the oligodendrocyte lineage.
Testai FD; Landek MA; Dawson G
J Neurosci Res; 2004 Jan; 75(1):66-74. PubMed ID: 14689449
[TBL] [Abstract][Full Text] [Related]
32. Identification of neutral and acidic sphingomyelinases in Helicobacter pylori.
Lin YL; Liu JS; Chen KT; Chen CT; Chan EC
FEBS Lett; 1998 Feb; 423(2):249-53. PubMed ID: 9512367
[TBL] [Abstract][Full Text] [Related]
33. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes.
Magnoni C; Euclidi E; Benassi L; Bertazzoni G; Cossarizza A; Seidenari S; Giannetti A
Toxicol In Vitro; 2002 Aug; 16(4):349-55. PubMed ID: 12110272
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.
Opreanu M; Lydic TA; Reid GE; McSorley KM; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3253-63. PubMed ID: 20071681
[TBL] [Abstract][Full Text] [Related]
35. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide.
Farooqui AA; Horrocks LA; Farooqui T
J Neurosci Res; 2007 Jul; 85(9):1834-50. PubMed ID: 17393491
[TBL] [Abstract][Full Text] [Related]
36. Involvement of sphingomyelinases in TNF signaling pathways.
Krönke M
Chem Phys Lipids; 1999 Nov; 102(1-2):157-66. PubMed ID: 11001570
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
Adada M; Luberto C; Canals D
Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
[TBL] [Abstract][Full Text] [Related]
38. Sphingomyelinase activity of Trichomonas vaginalis extract and subfractions.
González-Salazar F; Garza-González JN; Hernandez-Luna CE; Mata-Cárdenas BD; Carranza-Rosales P; Castro-Garza JE; Hernández-García ME; Vargas-Villarreal J
Biomed Res Int; 2013; 2013():679365. PubMed ID: 24024206
[TBL] [Abstract][Full Text] [Related]
39. The extended family of neutral sphingomyelinases.
Clarke CJ; Snook CF; Tani M; Matmati N; Marchesini N; Hannun YA
Biochemistry; 2006 Sep; 45(38):11247-56. PubMed ID: 16981685
[TBL] [Abstract][Full Text] [Related]
40. Secretory sphingomyelinase.
Tabas I
Chem Phys Lipids; 1999 Nov; 102(1-2):123-30. PubMed ID: 11001566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
